Caribou Biosciences (CRBU) Return on Equity: 2020-2025
Historic Return on Equity for Caribou Biosciences (CRBU) over the last 5 years, with Sep 2025 value amounting to -1.03%.
- Caribou Biosciences' Return on Equity fell 47.00% to -1.03% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.03%, marking a year-over-year decrease of 47.00%. This contributed to the annual value of -0.48% for FY2024, which is 17.00% down from last year.
- Latest data reveals that Caribou Biosciences reported Return on Equity of -1.03% as of Q3 2025, which was down 17.91% from -0.87% recorded in Q2 2025.
- In the past 5 years, Caribou Biosciences' Return on Equity registered a high of 1.27% during Q1 2021, and its lowest value of -1.03% during Q3 2025.
- For the 3-year period, Caribou Biosciences' Return on Equity averaged around -0.55%, with its median value being -0.44% (2023).
- In the last 5 years, Caribou Biosciences' Return on Equity tumbled by 215bps in 2021 and then rose by 7bps in 2022.
- Caribou Biosciences' Return on Equity (Quarterly) stood at -0.17% in 2021, then dropped by 17bps to -0.34% in 2022, then climbed by 4bps to -0.30% in 2023, then crashed by 32bps to -0.62% in 2024, then plummeted by 47bps to -1.03% in 2025.
- Its Return on Equity stands at -1.03% for Q3 2025, versus -0.87% for Q2 2025 and -0.70% for Q1 2025.